A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial
Neurology Open Access | April 25, 2025 | Volume: 1 | Issue: 2 | Pages: No page available
10.1212/wn9.0000000000000007
| PMID 40625668